PEG-interferon α-2b plus ribavirin for treatment of patients with chronic hepatitis C who have previously failed to achieve a sustained virologic response following interferon A or interferon α-2b plus ribavirin therapy.

被引：0
|
作者：
Sulkowski, M
Rothstein, KD
Stein, L
Godofsky, E
Shoultz, D
Hudnall, R
Huff, M
Dieterich, D
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] PPD Dev, Seattle, WA USA
[5] Hepatitis Resource Network, Tacoma, WA USA
[6] NYU, Sch Med, New York, NY USA
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
987
引用
收藏
页码：419A / 419A
页数：1
相关论文
共 50 条
  • [41] Virologic response in patients with chronic hepatitis C after treatment with interferon 2b alone or in combination with ribavirin.
    Futuh, ARA
    Solayman, AEM
    El Hendawy, SM
    El Hadad, SM
    Omar, MM
    Kamel, MM
    HEPATOLOGY, 2002, 36 (04) : 589A - 589A
  • [42] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [43] Treatment of chronic hepatitis C in HIV infected patients (pts) with pegylated interferon alpha 2b (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2b
    Cargnel, A
    Angeli, E
    Mainini, A
    Casella, A
    Gubertini, G
    Giorgi, R
    Orlando, G
    Duca, PG
    JOURNAL OF HEPATOLOGY, 2003, 38 : 132 - 132
  • [44] A COST-EFFECTIVENESS EVALUATION-RETREATMENT WITH PEGYLATED INTERFERON ALFA 2B PLUS RIBAVIRIN IN HEPATITIS C PATIENTS WHO HAVE PREVIOUSLY RECEIVED INTERFERON-BASED THERAPY AND FAILED TO ATTAIN A SUSTAINED VIROLOGICAL RESPONSE
    Gibbons, C. J.
    Morris, J.
    O'Sullivan, A. K.
    VALUE IN HEALTH, 2008, 11 (06) : A520 - A520
  • [45] Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience
    Schvarcz, R
    Ando, Y
    Sonnerborg, A
    Weiland, O
    JOURNAL OF HEPATOLOGY, 1995, 23 : 17 - 21
  • [46] Comparison of ribavirin with PEG-interferon α-2a or with α-2b in treatment-naive patients
    Webb, Amy
    Poy, Isela
    Patel, Rikin
    Ali, Olga
    Page, Robert
    Kashi, Maryam
    Herrera, Ana
    Schoolfield, John
    Brock, Paul
    Hoyumpa, Anastacio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S181 - S182
  • [47] Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients
    Lee, Seok
    Kim, In Hee
    Kim, Seong Hun
    Kim, Sang Wook
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Dae Ghon
    Lee, Chang Seop
    Choi, Chang Soo
    Cho, Eun Young
    Kim, Haak Cheoul
    INTERVIROLOGY, 2010, 53 (03) : 146 - 153
  • [48] Interferon Alpha 2b in Combination with Ribavirin as a Treatment for Chronic Hepatitis C
    Mandokhel, Sherbet Khan
    Aziz-U-Rehman
    Khan, Mohammad Saleem
    Azeemullah
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2011, 5 (01): : 168 - 171
  • [49] Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy
    Lo Iacono, O
    Castro, A
    Diago, M
    Moreno, JA
    Fernandez-Bermejo, M
    Vega, P
    García, V
    Carbonell, P
    Sanz, P
    Borque, MJ
    García-Buey, L
    García-Monzón, C
    Pedreira, J
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (04) : 463 - 469
  • [50] Prediction of response to retreatment with interferon alfa 2B in chronic hepatitis C patients who previously failed 24 weeks of interferon alpha therapy.
    Tong, M
    Blatt, LM
    Tong, L
    Sayadzadeh, K
    Conrad, A
    GASTROENTEROLOGY, 1998, 114 (04) : A1355 - A1355
12345